New Paper Published: Plasma S100β is a Predictor for Pathology and Cognitive Decline in Alzheimer’s Disease

This study highlights plasma S100β as a promising non-invasive biomarker for early detection and progression monitoring of Alzheimer’s disease. Given its strong association with cognitive decline and AD pathology, S100β could serve as a valuable diagnostic tool, addressing the urgent need for accessible biomarkers to guide early interventions and treatment strategies.

View Publication

Recent Posts

BHL Holiday Party

The BHL Annual Holiday Party brought the team together to mark the end of the year. We shared food, spent time together, and played a white elephant gift exchange. It was a nice opportunity to connect outside the lab!

Read More »
December 20, 2025

BHL Winter Retreat

We held our annual BHL Winter Retreat to reflect on our achievements in 2025 and provide an outlook on 2026. Every lab member gave a presentation, we discussed and shared ideas, and set goals for the coming months.

Read More »
December 19, 2025

Bjoern attended the AES Meeting in Atlanta

Bjoern attended the AES Annual Meeting in Atlanta and presented a poster on the team’s findings on CBD in epilepsy. Bjoern met with former lab members and colleagues, and learned about current advances in epilepsy research and emerging therapies.

Read More »
December 5, 2025